Ethical Requirements That Must be Met Before the Introduction of New Procedures
Author:
- 1 September 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 378 (378) , 15-22
Abstract
For orthopaedic care of patients to continue to improve, new approaches, both diagnostic and therapeutic, must be continually developed. To verify that a new approach actually provides improved outcomes, these innovations must be subjected to rigorous scientific study. However, because outcomes of clinical interventions only can be studied in human subjects, these studies must not only meet scientific criteria, they also must meet strict ethical criteria. The Declaration of Helsinki, a document prepared by the World Medical Association that originally was written in 1964, revised substantially in 1975, and most recently revised in 1996, provides guidelines for such studies. In addition to satisfying ethical requirements, clinical investigators also face various complex issues that must be dealt with in the performance of clinical research studies. One of the most difficult issues is the conflict between a physician's concern for the well-being of his or her patients and the need for protocol driven trials. No matter how enthusiastic surgeons may be about a new therapeutic approach, they must recognize that they are responsible to scientifically validate their innovative approach with a well controlled clinical trial using valid functional outcome measures.Keywords
This publication has 20 references indexed in Scilit:
- The Treatment of Neurologically Impaired Children Using PatterningPediatrics, 1999
- Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's DiseaseNew England Journal of Medicine, 1999
- Is There a Difference? A Prospective Study Comparing Lateral and Standard SMAS Face Lifts with Extended SMAS and Composite RhytidectomiesPlastic and Reconstructive Surgery, 1996
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Failure of Extracranial–Intracranial Arterial Bypass to Reduce the Risk of Ischemic StrokeNew England Journal of Medicine, 1985
- Patients’ Preferences in Randomized Clinical TrialsNew England Journal of Medicine, 1984
- A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma.Journal of Clinical Oncology, 1984
- Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic SarcomaNew England Journal of Medicine, 1974
- An Evaluation of Internal-Mammary-Artery Ligation by a Double-Blind TechnicNew England Journal of Medicine, 1959